Indokem Limited
Indokem Limited (INDOKEM): company summary
The company's annual revenue fell 4.9% to ₹169 crore, while net profit dropped 41.1% to ₹2 crore.
Indokem Limited (INDOKEM) is a micro-cap Chemicals company valued at ₹2,033 crore operating in Specialty Chemicals on the NSE and BSE.
- Recent price move
- Indokem Limited last traded at ₹715, modestly up 1.42% on the day.
- Recent developments
- On 2026-06-30, the company reported a net profit of ₹1 crore for the latest quarter, up from ₹1 crore in the same quarter a year earlier, showing stability in profitability. The company's promoter holding remained at 68.67%, with no significant changes in foreign or domestic institutional holdings.
- Financial performance
- The company's annual revenue fell 4.9% to ₹169 crore, while net profit dropped 41.1% to ₹2 crore. The latest quarter saw revenue rise 12.2% year-on-year to ₹47 crore, and net profit surged 52.9% to ₹1 crore, indicating improved performance in the most recent period.
- Valuation multiples
- The stock trades at 1067.2 times earnings, 36.72 times book value.
- Things to watch
- The company's net profit margin narrowed to 1.1% from 1.8% in the prior year, reflecting pressure on profitability. The stock is 3.0% below its 52-week high, and net profit fell 41.1% annually, indicating challenges in maintaining earnings growth.
- Where it stands
- Indokem Limited ended the latest quarter with a net profit of ₹1 crore, up 52.9% from the same quarter a year earlier, while annual net profit fell 41.1% to ₹2 crore. The stock is 3.0% below its 52-week high, and the net profit margin has declined to 1.1%.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (7.5) and momentum (7.5), but held back by valuation (0.0). Growth looks strong at 7.5, but that is offset by valuation at 0.0 and quality at 0.3. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Revenue compounding 27% a year
- Loss-making in some of the last 5 years
- Quality is weak (0.3/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Specialty Chemicals
Explore Indokem Limited’s valuation
Free deep-dive tools · no sign-up
Indokem Limited peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value Indokem Limited with the ratios and calculators DocStoX uses in its analysis.

